Clinical trial: Backup with combivir (AZT/3TC) or single dose (Sd) Truvada (FTC/TDF) in order to avoid NNRTI resistance after Sd nevirapine for the prevention of mother-to-child transmission (MTCT)

Trial Profile

Clinical trial: Backup with combivir (AZT/3TC) or single dose (Sd) Truvada (FTC/TDF) in order to avoid NNRTI resistance after Sd nevirapine for the prevention of mother-to-child transmission (MTCT)

Completed
Phase of Trial: Phase III

Latest Information Update: 25 Feb 2016

At a glance

  • Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary) ; Lamivudine/zidovudine; Nevirapine
  • Indications HIV infections
  • Focus Therapeutic Use
  • Acronyms COMTRU
  • Most Recent Events

    • 17 Feb 2009 Planned number of patients changed from 300 to 450 as reported by ClinicalTrials.gov.
    • 17 Feb 2009 Planned end date changed from 1 Mar 2008 to 1 Nov 2010 as reported by ClinicalTrials.gov.
    • 23 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top